MTIF2P1

Across TCGA pan-cancer cohorts, MTIF2P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MTIF2P1’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where MTIF2P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MTIF2P1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

LUAD, LUSC, and STAD are the cancer types where MTIF2P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MTIF2P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.145	<.001	5	view →
LUSC	All	All	+0.105	<.001	5	view →
STAD	All	All	+0.062	.003	5	view →
LIHC	All	All	+0.064	.010	2	view →
THCA	Male	IV	−0.126	.013	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MTIF2P1–LUAD

Open the LUAD breakdown →